Initial hypoalbuminemia and hyperlipidemia persist during chronic peritoneal dialysis in children

D Scolnik1, J W Balfe

  • 1Division of Nephrology, Hospital for Sick Children, Toronto, Ontario, Canada.

Insights

Pediatric peritoneal dialysis (PD) patients exhibit high rates of abnormal lipid profiles and low albumin, which persist during treatment. These cardiovascular risk factors require serious consideration in children with renal failure.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Risk Factors
  • Metabolic Disorders

Background:

  • Peritoneal dialysis (PD) is a crucial renal replacement therapy for children.
  • Lipid profiles and albumin levels are vital indicators of metabolic health and cardiovascular risk in pediatric patients.
  • Understanding these parameters in young PD patients is essential for long-term health management.

Purpose of the Study:

  • To document serum lipid values in pediatric peritoneal dialysis (PD) patients, especially the very young.
  • To investigate the relationship between serum lipid levels and serum albumin in these patients.
  • To assess the impact of PD on lipid profiles and albumin levels over time.

Main Methods:

  • Retrospective review of pediatric PD patients over an 11-year period.
  • Inclusion criteria required at least four simultaneous measurements of serum lipids and albumin over a minimum of 90 days of PD.
  • Analysis included patients on continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD), with a focus on those under 5 years old.

Main Results:

  • Hypoalbuminemia was prevalent (43%), most marked in younger CAPD patients.
  • Average serum cholesterol and triglyceride levels were significantly elevated compared to age-appropriate norms.
  • Low high-density lipid levels were observed in a substantial proportion of patients.
  • These abnormalities remained largely unchanged during PD treatment across all groups.

Conclusions:

  • Pediatric PD patients, including very young children, have a high incidence of hypoalbuminemia and dyslipidemia (hypertriglyceridemia, hypercholesterolemia, low HDL).
  • These metabolic abnormalities persist throughout PD treatment and were not significantly altered.
  • Abnormal lipid profiles represent a neglected cardiovascular risk factor in children with renal failure, necessitating therapeutic interventions.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...